The benefits that it contracts to suppress harmful habits, in order to build a strong and resistant bone, and prevent its loss of bone mass to prevent fractures in future stages.
The lack of daily exercise, the deficiency of vitamin D and calcium consumption (milk and derivatives), as well as smoking and alcoholism, are risk factors for osteoporosis, as reported by the person in charge of the State Program of Aging of the services of Health of Oaxaca (SSO), Carlos Castellanos.
365 Everyday Value, Vitamin D3 400 IU, 100 ct
Who explained that fractures are the symptom and the main consequence of this disease, since the skeleton becomes porous, increasing the number and size of the cavities, and consequently is more fragile.
He warned that women are the most vulnerable population group, since the maximum amount of bone mass is usually lower than the male and the cessation of production of female sex hormones by the ovary, some may suffer a faster and faster loss of bone, which can lead to post-menopausal osteoporosis.
Therefore, he stressed the importance of raising awareness among the young population, especially the Oaxacans, that they should ingest an adequate amount of calcium in adolescence and youth, that they should carry out correct and constant physical exercise.
He also emphasized the benefits of suppressing harmful habits, in order to build a strong and resistant bone, and prevent its loss of bone mass to prevent fractures in future stages.
Since he mentioned that the complications associated with fractures include an increase in mortality and an increase in the risk of suffering new falls, causing partial disability or require special care.
In this regard, he stressed that during the administration of the governor, Gabino Cué Monteagudo, and the holder of the SSO, Germán Tenorio Vasconcelos, prevention strategies have been promoted for a healthy life that helps to take care of the bones, strengthen them and reduce the damages that put the health of the Oaxacans at risk.
He added that working on the factors that can improve the prognosis is key to prevent the incidence of this condition increases, "healthy bones require good habits," he concluded.
Osteoporosis: what it is, symptoms, diagnosis and treatment
What is it
Osteoporosis is a skeletal disease in which there is a decrease in the density of bone mass. Thus, the bones become more porous, increases the number and size of the cavities or cells that exist inside them, they are more fragile, they resist the blows worse and they break more easily.
Causes
Many metabolic changes occur throughout life, alternating phases of destruction and bone formation. These phases are regulated by different hormones, physical activity, diet, toxic habits and vitamin D, among other factors.
Under normal conditions, a person reaches 30-35 years a maximum amount of bone mass ("peak bone mass"). From that moment, there is a natural loss of bone mass .
Women have more frequent osteoporosis for several reasons: their peak of bone mass is usually lower than that of men and with menopause bone loss is accelerated (postmenopausal osteoporosis).
There are many other causes of osteoporosis: alcoholism, drugs (glucocorticoids, hormone treatment used for the treatment of breast and prostate cancer ...), rheumatic inflammatory diseases , endocrine, liver, kidney failure, among others
symptom
Osteoporosis is called a silent epidemic because it does not manifest symptoms until the loss of bone is so important that fractures appear. The most frequent fractures are the vertebral, hip and wrist fractures (Colles fracture or distal end of the radius). Hip fracture is especially important because it is considered a serious event because it requires surgical intervention, hospital admission and a loss of quality of life for the patient, even for a short period of time.
Prevalence
This disease mainly affects women after menopause, although it can also do so earlier or affect men, adolescents and even children. Specifically, in Spain, approximately 2 million women suffer from osteoporosis , with a prevalence in the postmenopausal population of 25% (1 in 4). It is estimated that this disease is responsible for about 25,000 fractures every year. Approximately 1 in 3 women and 1 in 5 men over 50 will suffer an osteoporotic fracture in their lifetime.
Diagnosis
Although it is a silent disease, currently rheumatologists have a wide range of tools for early diagnosis and thus adapt the treatment, either to prevent the loss of bone mass or to combat osteoporosis.
There are life habits that can help improve bone quality such as: adequate calcium intake, physical exercise and no smoking. The specific amount of calcium varies with age, but many adults will need 1,000 to 1,500 mg per day. This intake can be made with natural foods rich in calcium (especially milk and its derivatives) or as supplements in the form of medicines (calcium salts). In this last case there should be a control of your doctor about the amount and the administration schedule.
In the same way, vitamin D is a fundamental substance for bone . Their daily needs are mainly achieved by the formation of it on the skin when it receives the effect of solar irradiation.
Treatment
The goal of osteoporosis treatment is to reduce the number of fragility fractures.
As a generalized measure, it is recommended to maintain healthy lifestyle habits, such as a balanced diet rich in calcium , quitting tobacco and excessive consumption of alcohol, as well as exercising daily with control to avoid falls. In addition, some people may require calcium and vitamin D supplements.
The antiresorptive treatment is one that prevents the loss of bone mass. This group includes drugs such as bisphosphonates (alendronate, risedronate, zoledronate ...), denosumab, selective modulators of estrogen receptors (raloxifene, bazedoxifene) and estrogens. The osteoformador treatment , as the name suggests, stimulates the formation of new bone and within this group is included teriparatide. Finally, the drug that has a mixed mechanism of action (antiresorptive and osteoformer) is strontium ranelate.
However, the rheumatologist will assess the characteristics of the patient, their pathological background and risk factors for osteoporosis and decide in each situation which is the most appropriate drug in each case.